Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

<h3>Introduction</h3><p dir="ltr">Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre-direct-acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor to...

Full description

Saved in:
Bibliographic Details
Main Author: Mohamad M. Alkadi (14778640) (author)
Other Authors: Essa A. Abuhelaiqa (14778643) (author), Mostafa F. Elshirbeny (14778646) (author), Ahmed F. Hamdi (14778649) (author), Omar M. Fituri (14778652) (author), Muhammad Asim (2235472) (author), Saad R. Alkaabi (14778655) (author), Moutaz F. Derbala (14778658) (author), Mona E. Jarman (14778661) (author), Adel M. Ashour (14778664) (author), Awais Nauman (14778667) (author), Yousuf K. Al Maslamani (14778670) (author), Adeel A. Butt (3697705) (author), Hassan A. Al‐Malki (14778673) (author)
Published: 2020
Subjects:
Biomedical and clinical sciences
Clinical sciences
Immunology
hepatitis C
immunosuppression
kidney function
kidney transplantation
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items